Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed this Form 8-K on November 16, 2016, to report a corporate event under Item 8.01 (Other Events). The filing discloses the creation of a new subsidiary named AmnioStem LLC.
Financial Metrics
This filing does not provide specific financial data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change reported is the establishment of the new subsidiary, AmnioStem LLC. No financial comparisons to prior periods are included in this report.
Guidance, Outlook, and Risks
The filing references a press release (Exhibit 99.1) that may contain forward-looking statements. Management cautions that actual results could differ materially from anticipated results due to various factors, including those discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. The Company assumes no obligation to update these forward-looking statements.
Key Facts for Investor Verification
- Verify the strategic purpose and operational scope of the new subsidiary, AmnioStem LLC.
- Review the full text of the press release dated November 16, 2016 (Exhibit 99.1) for details on the subsidiary.
- Consult the Form 10-K for the year ended December 31, 2015, to understand the risk factors referenced in this filing.